In terms of the latter, a large body of data indicates that COVID-19 is often associated with ADAMTS13 deficiency [104,105,106]; however, this may often be due to exhaustion of ADAMTS13 reserves due to the associated elevated release of VWF, rather than any immune basis or TTP. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.